Share on StockTwits

Vital Therapies (NYSE:VTL) Director Muneer A. Satter acquired 360,966 shares of the stock in a transaction dated Wednesday, April 23rd. The shares were purchased at an average cost of $12.00 per share, with a total value of $4,331,592.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Vital Therapies (NYSE:VTL) traded down 0.57% during mid-day trading on Wednesday, hitting $12.25. The stock had a trading volume of 41,994 shares. Vital Therapies has a 1-year low of $11.85 and a 1-year high of $12.50. The stock has a 50-day moving average of $12.16 and a 200-day moving average of $12.16. The company’s market cap is $258.7 million.

Vital Therapies, Inc is a biotherapeutic company. The Company focused on developing a cell-based therapy targeting the treatment of all forms of acute liver failure.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.